|
| 泰恩康(301263)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-03-31 | 15709.74 | 36.92% | 42007.22 | 542.53 | 26292.54 | 61.79% | 首发原股东限售股份 | | 2023-06-29 | 3939.75 | 9.26% | 26839.26 | 15710.49 | 22900.26 | 53.82% | 首发原股东限售股份 | | 2023-03-29 | 7355.87 | 31.12% | 12722.37 | 10916.38 | 5366.50 | 22.70% | 首发原股东限售股份,首发战略配售股份 | | 2022-09-29 | 278.98 | 1.18% | 5366.50 | 18272.25 | 5366.50 | 22.70% | 首发机构配售股份 | | 2022-03-29 | 5087.52 | 21.52% | 5087.52 | 18551.23 | 5087.52 | 21.52% | 首发一般股份 |
|